Alirocumab, Placebo product for REGN727
ACAV2018
Approved small_molecule active
Quick answer
Alirocumab, Placebo product for REGN727 for Cardiac allograft vaculopathy in recent heart transplant recipients is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Cardiac allograft vaculopathy in recent heart transplant recipients
- Phase
- Approved
- Modality
- small_molecule
- Status
- active